| scholarly article | Q13442814 |
| P50 | author | Jesús Prieto | Q28324697 |
| Luis Bujanda | Q42426407 | ||
| Jesus M Banales | Q64913476 | ||
| P2093 | author name string | Nicholas F LaRusso | |
| Elena Sáez | |||
| Juan F Medina | |||
| Sarai Sarvide | |||
| Patrick Splinter | |||
| Aura D Urribarri | |||
| Pamela S Tietz Bogert | |||
| Miriam Uriz | |||
| P2860 | cites work | Primary biliary cirrhosis | Q21202919 |
| Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants | Q24633806 | ||
| miRBase: tools for microRNA genomics | Q24649872 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Molecular cloning and characterization of the human AE2 anion exchanger (SLC4A2) gene | Q28303267 | ||
| Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease | Q28569447 | ||
| Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger | Q28582973 | ||
| Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis | Q28943317 | ||
| Genomic variants associated with primary biliary cirrhosis | Q33693726 | ||
| Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis | Q33786505 | ||
| miRNAs: effectors of environmental influences on gene expression and disease | Q34070399 | ||
| Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis | Q34087671 | ||
| Primary biliary cirrhosis: a 2010 update | Q34106999 | ||
| Pathogenesis of primary biliary cirrhosis | Q34653850 | ||
| The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). | Q34717186 | ||
| Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells | Q36330872 | ||
| Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis | Q36495172 | ||
| MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease | Q36945198 | ||
| Ursodeoxycholic acid for the treatment of primary biliary cirrhosis | Q36967686 | ||
| The causes of primary biliary cirrhosis: Convenient and inconvenient truths | Q37039889 | ||
| Primary biliary cirrhosis is associated with altered hepatic microRNA expression | Q37233506 | ||
| MicroRNAs: key modulators of posttranscriptional gene expression. | Q37339409 | ||
| Experimental evidence on the immunopathogenesis of primary biliary cirrhosis | Q37661371 | ||
| The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies | Q37781024 | ||
| Biological functions of microRNAs: a review | Q37803556 | ||
| Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis | Q37892296 | ||
| Approaches to the pathogenesis of primary biliary cirrhosis through animal models | Q37921498 | ||
| A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. | Q39471132 | ||
| Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines | Q41464352 | ||
| Defective regulation of cholangiocyte Cl-/HCO3(-) and Na+/H+ exchanger activities in primary biliary cirrhosis. | Q42521707 | ||
| Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations | Q43120578 | ||
| Bicarbonate secretion of mouse cholangiocytes involves Na(+)-HCO(3)(-) cotransport in addition to Na(+)-independent Cl(-)/HCO(3)(-) exchange. | Q43205152 | ||
| Genetic factors of susceptibility and of severity in primary biliary cirrhosis. | Q44396311 | ||
| Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis | Q45877492 | ||
| Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. | Q53648123 | ||
| Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. | Q54372307 | ||
| Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis | Q71949350 | ||
| Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver | Q72430990 | ||
| Abnormal expression of anion exchanger genes in primary biliary cirrhosis | Q72840980 | ||
| Assessment of biliary bicarbonate secretion in humans by positron emission tomography | Q77921993 | ||
| Update on primary biliary cirrhosis | Q83974781 | ||
| Primary biliary cirrhosis | Q84230884 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| primary biliary cholangitis | Q1072420 | ||
| P304 | page(s) | 687-697 | |
| P577 | publication date | 2012-07-10 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis | |
| P478 | volume | 56 |
| Q34479345 | Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis |
| Q61952476 | Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury |
| Q52355268 | An impaired biliary bicarbonate umbrella may be involved in dysregulated autophagy in primary biliary cholangitis. |
| Q54282638 | Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. |
| Q46206938 | Bicarbonate Transport During Enamel Maturation. |
| Q42292374 | Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice |
| Q55324101 | Biomarkers for primary biliary cholangitis: current perspectives. |
| Q36557102 | CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis |
| Q60912697 | Calcium Signaling in Cholangiocytes: Methods, Mechanisms, and Effects |
| Q55071942 | Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'. |
| Q34494216 | Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. |
| Q55059313 | Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'. |
| Q34287861 | Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis |
| Q64913364 | Cholangiocyte pathobiology. |
| Q34206508 | Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis |
| Q91733388 | Current and potential treatments for primary biliary cholangitis |
| Q57128794 | Diagnostic and therapeutic potentials of microRNAs in cholangiopathies |
| Q39250374 | EGR1 is critical for gastrin-dependent upregulation of anion exchanger 2 in gastric cancer cells |
| Q38254730 | Effect of drug transporter pharmacogenetics on cholestasis |
| Q52885250 | Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis. |
| Q38565478 | Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity |
| Q87955785 | Genetic and epigenetic influences on the loss of tolerance in autoimmunity |
| Q35236464 | Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanisms |
| Q34035361 | HDAC6 inhibition restores ciliary expression and decreases tumor growth |
| Q28572123 | HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis |
| Q35128292 | Identification of microRNAs in the coral Stylophora pistillata |
| Q35185224 | Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases |
| Q92166741 | MRP3-mediated chemoresistance in cholangiocarcinoma: Target for chemosensitization through restoring SOX17 expression |
| Q38774857 | Management of cholestatic disease in 2017. |
| Q36144748 | MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis. |
| Q35202716 | MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1 |
| Q47784988 | MiRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation. |
| Q35868382 | MicroRNA 224 Regulates Ion Transporter Expression in Ameloblasts To Coordinate Enamel Mineralization |
| Q38078996 | MicroRNA control in the development of systemic autoimmunity |
| Q92251764 | MicroRNA-506 Is Involved in Regulation of the Occurrence of Lipopolysaccharides (LPS)-Induced Pulpitis by Sirtuin 1 (SIRT1) |
| Q26865762 | MicroRNAs and benign biliary tract diseases |
| Q33991899 | MicroRNAs in Cholangiopathies |
| Q36410357 | MicroRNAs in biliary diseases. |
| Q33880442 | MicroRNAs in liver disease |
| Q26783579 | MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment |
| Q49559317 | Mouse Models of SLC4-linked Disorders of HCO3- Transporter Dysfunction |
| Q92135848 | New Therapeutic Targets in Autoimmune Cholangiopathies |
| Q47223909 | New therapies target the toxic consequences of cholestatic liver disease |
| Q42375647 | Novel strategies and therapeutic options for the management of primary biliary cholangitis |
| Q99565419 | Overexpression of MiR-506 in Jurkat (Acute T Cell Leukemia) Cell Line |
| Q39440062 | Pathobiology of biliary epithelia. |
| Q90400187 | Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis |
| Q89908963 | Physiological Significance of Ion Transporters and Channels in the Stomach and Pathophysiological Relevance in Gastric Cancer |
| Q53354692 | Polarized release of hepatic microRNAs into bile and serum in response to cellular injury and impaired liver function. |
| Q34801354 | Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506. |
| Q104288323 | Primary biliary cholangitis |
| Q91826723 | Primary biliary cholangitis: pathogenesis and therapeutic opportunities |
| Q38554677 | Primary biliary cirrhosis: safety and benefits of established and emerging therapies |
| Q89623970 | Promoter hypermethylation of the AE2/SLC4A2 gene in PBC |
| Q37662251 | Recent advances in the morphological and functional heterogeneity of the biliary epithelium |
| Q57139557 | Rifampicin Induces Bicarbonate-Rich Choleresis in Rats: Involvement of Anion Exchanger 2 |
| Q37488881 | Role of AE2 for pHi regulation in biliary epithelial cells. |
| Q34276575 | Role of cholangiocytes in primary biliary cirrhosis |
| Q35159893 | Role of novel retroviruses in chronic liver disease: assessing the link of human betaretrovirus with primary biliary cirrhosis |
| Q48821774 | SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma. |
| Q39002205 | Saturated free fatty acids induce cholangiocyte lipoapoptosis. |
| Q39979273 | Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice. |
| Q48553032 | Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. |
| Q34408701 | Serum microRNAs as potential biomarkers of primary biliary cirrhosis |
| Q37418108 | Soluble Adenylyl Cyclase Regulates Bile Salt-Induced Apoptosis in Human Cholangiocytes. |
| Q35942610 | The Cholangiopathies |
| Q98185020 | The Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury |
| Q34333694 | The SLC4 family of bicarbonate (HCO₃⁻) transporters |
| Q26740283 | The emerging role of miR-506 in cancer |
| Q26801377 | The immunogenetics of primary biliary cirrhosis: A comprehensive review |
| Q38261684 | The physiological roles of secretin and its receptor. |
| Q91940744 | Up-regulation of miR-let7a-5p Leads to Decreased Expression of ABCC2 in Obstructive Cholestasis |
| Q33840969 | Why Doesn't Primary Biliary Cholangitis Respond to Immunosuppressive Medications? |
| Q39017343 | miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer |
| Q38848862 | miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1. |
| Q36250621 | microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1) |
| Q49999392 | microRevolution in understanding primary biliary cholangitis pathophysiology |
Search more.